Innospec Inc. (IOSP) Stock Forecast

NASDAQ: IOSPAnalyst ratings, price target and estimates.

IOSP analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
4.67 / 5 from 3 analysts
Price target
$101.00
average of analyst targets
Upside to target
+4.3%
from the latest close
Next earnings
November 3, 2026
EPS estimate $1.28
52-week range
$65.89 – $98.72

IOSP analyst ratings

3 analysts
Strong buy
267%
Buy
133%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

IOSP price target

Price $96.81Target $101.00
52-week low $65.8952-week high $98.72

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

IOSP earnings per share estimates

Innospec Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)$1.26$1.24$1.29$1.12+12.5%3
Current fiscal year (2026)$4.92$4.75$5.01$5.27−6.6%3
Next fiscal year (2027)$6.17$6.00$6.45$4.92+25.3%3

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

IOSP revenue estimates

Innospec Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$479.2M$458.0M$495.3M+8.4%3
Current fiscal year (2026)$1.91B$1.83B$1.96B+7.1%3
Next fiscal year (2027)$2.02B$1.93B$2.09B+5.8%3

IOSP EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

IOSP revenue: reported and forecast

Reported revenueEstimate (average; low–high)

IOSP EPS estimate revisions

Innospec Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)$1.26$1.27$1.27$1.27$1.26+0.3%2 up · 0 down
Current fiscal year (2026)$4.81$4.94$4.94$4.94$4.92+2.4%2 up · 0 down
Next fiscal year (2027)$6.08$6.15$6.15$6.15$6.17+1.4%1 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

IOSP earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; IOSP beat in 12 of 12.

What analysts expect from IOSP

3 analysts cover Innospec; their consensus rating is strong buy (4.67 on a 1–5 scale, where 5 is a strong buy). The average price target is $101.00, 4.3% above the latest close of $96.81. Analysts expect earnings of $4.92 per share for 2026, −6.6% from a year earlier. For 2027 the average estimate is $6.17 per share on revenue of $2.0 billion. Innospec beat the EPS estimate in 12 of the last 12 quarters.

Related: IOSP income statement, IOSP key metrics, IOSP chart. See the IOSP stock overview for the latest quote and news.

IOSP forecast FAQ

What is Innospec's price target?

The average analyst price target for Innospec is $101.00, 4.3% above the latest close of $96.81.

Is Innospec a buy, hold or sell?

Of 3 analysts covering Innospec, 2 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Innospec's EPS forecast?

Analysts forecast $4.92 per share for 2026 (range $4.75 to $5.01); for 2027 the estimate is $6.17.

What is Innospec's revenue forecast?

The average revenue estimate for 2026 is $1.9 billion, growth of 7.1%; for 2027 it is $2.0 billion.

When does Innospec report earnings?

Innospec is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes; the EPS estimate is $1.28.

Does Innospec usually beat earnings estimates?

Innospec reported EPS at or above the analyst estimate in 12 of the last 12 quarters.

Specialty Chemicals: forecast